Session Details
[SY9]Symposium 9 : Data Science for Virology: From Models to Real-World Impact
Wed. Nov 4, 2026 3:20 PM - 5:20 PM JST
Wed. Nov 4, 2026 6:20 AM - 8:20 AM UTC
Wed. Nov 4, 2026 6:20 AM - 8:20 AM UTC
Room 1 (2F International Conference Room)
Chair: So Miyoshi (Clinical Pharmacology and Bioanalytics, Pfizer R&D Japan)
Shingo Iwami (Graduate School of Science, Nagoya University)
Shingo Iwami (Graduate School of Science, Nagoya University)
Opening Remarks
[SY9-1]Quantitative Systems Pharmacology and Model-Informed Drug Development for Anti-Viral Drugs and Vaccines
*Richard Allen1 (1. Translational Clinical Sciences, Pfizer Inc.)
[SY9-2]Optimal virologic endpoint selection allows efficient, rapid and small early phase trials for respiratory virus targeting antiviral agents
*Joshua T. Schiffer1,2, Chenhui Ma1 (1. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, 2. Department of Medicine, University of Washington, Seattle)
[SY9-3]Translating individual-level variation in susceptibility into population-level epidemic dynamics
*Fuminari Miura1,2,3 (1. Dutch National Institute for Public Health and the Environement (RIVM), 2. Leiden University Medical Centre (LUMC), 3. Nagasaki University)
[SY9-4]A Quantitative Framework for Droplet-Mediated Transmission in Respiratory Viral Infections
*Yong Dam Jeong1,2, Kazuki Kuga3, Shingo Iwami2 (1. Department of Applied Mathematics, Pukyong National University, Busan, Republic of Korea, 2. interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan, 3. Faculty of Engineering Sciences, Kyushu University, Fukuoka, Japan)